116 related articles for article (PubMed ID: 31907052)
41. Metabolic Control by Heat Stress Determining Cell Fate to Ferroptosis for Effective Cancer Therapy.
Xie S; Sun W; Zhang C; Dong B; Yang J; Hou M; Xiong L; Cai B; Liu X; Xue W
ACS Nano; 2021 Apr; 15(4):7179-7194. PubMed ID: 33861924
[TBL] [Abstract][Full Text] [Related]
42. Tailored-Made Polydopamine Nanoparticles to Induce Ferroptosis in Breast Cancer Cells in Combination with Chemotherapy.
Nieto C; Vega MA; Martín Del Valle EM
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808898
[TBL] [Abstract][Full Text] [Related]
43. Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy.
Liu X; Zhu X; Qi X; Meng X; Xu K
Int J Nanomedicine; 2021; 16():1037-1050. PubMed ID: 33603367
[TBL] [Abstract][Full Text] [Related]
44. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
[TBL] [Abstract][Full Text] [Related]
45. Electron-Accepting Micelles Deplete Reduced Nicotinamide Adenine Dinucleotide Phosphate and Impair Two Antioxidant Cascades for Ferroptosis-Induced Tumor Eradication.
Guo X; Liu F; Deng J; Dai P; Qin Y; Li Z; Wang B; Fan A; Wang Z; Zhao Y
ACS Nano; 2020 Nov; 14(11):14715-14730. PubMed ID: 33156626
[TBL] [Abstract][Full Text] [Related]
46. Cascade reaction-mediated efficient ferroptosis synergizes with immunomodulation for high-performance cancer therapy.
Li Z; Rong L
Biomater Sci; 2020 Nov; 8(22):6272-6285. PubMed ID: 33016289
[TBL] [Abstract][Full Text] [Related]
47. Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator.
He YJ; Liu XY; Xing L; Wan X; Chang X; Jiang HL
Biomaterials; 2020 May; 241():119911. PubMed ID: 32143060
[TBL] [Abstract][Full Text] [Related]
48. Hybrid Lipid Nanocapsules: A Robust Platform for mRNA Delivery.
Yadava SK; Reddy BPK; Prausnitz MR; Cicerone MT
ACS Appl Mater Interfaces; 2024 Apr; 16(13):15981-15992. PubMed ID: 38507686
[TBL] [Abstract][Full Text] [Related]
49. Gel-Dispersed Nanostructured Lipid Carriers Loading Thymol Designed for Dermal Pathologies.
Folle C; Marqués AM; Díaz-Garrido N; Carvajal-Vidal P; Sánchez López E; Suñer-Carbó J; Halbaut L; Mallandrich M; Espina M; Badia J; Baldoma L; García ML; Calpena AC
Int J Nanomedicine; 2024; 19():1225-1248. PubMed ID: 38348173
[TBL] [Abstract][Full Text] [Related]
50. Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis.
Ge A; He Q; Zhao D; Li Y; Chen J; Deng Y; Xiang W; Fan H; Wu S; Li Y; Liu L; Wang Y
J Cell Mol Med; 2024 Jan; 28(1):e18044. PubMed ID: 38140764
[TBL] [Abstract][Full Text] [Related]
51. New SDS-Based Polyelectrolyte Multicore Nanocarriers for Paclitaxel Delivery-Synthesis, Characterization, and Activity against Breast Cancer Cells.
Szwed M; Michlewska S; Kania K; Szczęch M; Marczak A; Szczepanowicz K
Cells; 2023 Aug; 12(16):. PubMed ID: 37626862
[TBL] [Abstract][Full Text] [Related]
52. Oxidative Status as an Attribute for Selective Antitumor Activity of Platinum-Containing Nanoparticles against Hepatocellular Carcinoma.
Wawrowicz K; Majkowska-Pilip A; Szwed M; Żelechowska-Matysiak K; Chajduk E; Bilewicz A
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499101
[TBL] [Abstract][Full Text] [Related]
53. Gallium(III) Complex with Cloxyquin Ligands Induces Ferroptosis in Cancer Cells and Is a Potent Agent against Both Differentiated and Tumorigenic Cancer Stem Rhabdomyosarcoma Cells.
Hreusova M; Novohradsky V; Markova L; Kostrhunova H; Potočňák I; Brabec V; Kasparkova J
Bioinorg Chem Appl; 2022; 2022():3095749. PubMed ID: 35502218
[TBL] [Abstract][Full Text] [Related]
54. Particle Engineering of Innovative Nanoemulsion Designs to Modify the Accumulation in Female Sex Organs by Particle Size and Surface Charge.
Busmann EF; Lucas H
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214035
[TBL] [Abstract][Full Text] [Related]
55. Supramolecular lipid nanoparticles as delivery carriers for non-invasive cancer theranostics.
Bukhari SZ; Zeth K; Iftikhar M; Rehman M; Usman Munir M; Khan WS; Ihsan A
Curr Res Pharmacol Drug Discov; 2021; 2():100067. PubMed ID: 34909685
[TBL] [Abstract][Full Text] [Related]
56. Enhancing the
El-Sheridy NA; El-Moslemany RM; Ramadan AA; Helmy MW; El-Khordagui LK
Drug Deliv; 2021 Dec; 28(1):906-919. PubMed ID: 33960245
[TBL] [Abstract][Full Text] [Related]
57. Drug Delivery Systems of Natural Products in Oncology.
Colone M; Calcabrini A; Stringaro A
Molecules; 2020 Oct; 25(19):. PubMed ID: 33036240
[TBL] [Abstract][Full Text] [Related]
58. Drug-Loaded Photosensitizer-Chitosan Nanoparticles for Combinatorial Chemo- and Photodynamic-Therapy of Cancer.
Pandya AD; Øverbye A; Sahariah P; Gaware VS; Høgset H; Masson M; Høgset A; Mælandsmo GM; Skotland T; Sandvig K; Iversen TG
Biomacromolecules; 2020 Apr; 21(4):1489-1498. PubMed ID: 32092254
[TBL] [Abstract][Full Text] [Related]
59. Biological response and cytotoxicity induced by lipid nanocapsules.
Szwed M; Torgersen ML; Kumari RV; Yadava SK; Pust S; Iversen TG; Skotland T; Giri J; Sandvig K
J Nanobiotechnology; 2020 Jan; 18(1):5. PubMed ID: 31907052
[TBL] [Abstract][Full Text] [Related]
60. Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.
Valsalakumari R; Yadava SK; Szwed M; Pandya AD; Mælandsmo GM; Torgersen ML; Iversen TG; Skotland T; Sandvig K; Giri J
Int J Pharm; 2021 Mar; 597():120217. PubMed ID: 33486035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
